Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15,377 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical outcomes in real-world patients with type 2 diabetes switching from first- to second-generation basal insulin analogues: Comparative effectiveness of insulin glargine 300 units/mL and insulin degludec in the DELIVER D+ cohort study.
Sullivan SD, Bailey TS, Roussel R, Zhou FL, Bosnyak Z, Preblick R, Westerbacka J, Gupta RA, Blonde L. Sullivan SD, et al. Among authors: gupta ra. Diabetes Obes Metab. 2018 Sep;20(9):2148-2158. doi: 10.1111/dom.13345. Epub 2018 Jun 25. Diabetes Obes Metab. 2018. PMID: 29938887 Free PMC article.
Glycaemic goal attainment and hypoglycaemia outcomes in type 2 diabetes patients initiating insulin glargine 300 units/mL or 100 units/mL: Real-world results from the DELIVER Naïve cohort study.
Bailey TS, Zhou FL, Gupta RA, Preblick R, Gupta VE, Berhanu P, Blonde L. Bailey TS, et al. Among authors: gupta ra, gupta ve. Diabetes Obes Metab. 2019 Jul;21(7):1596-1605. doi: 10.1111/dom.13693. Epub 2019 Apr 5. Diabetes Obes Metab. 2019. PMID: 30843339 Free PMC article.
Clinical outcomes in high-hypoglycaemia-risk patients with type 2 diabetes switching to insulin glargine 300 U/mL versus a first-generation basal insulin analogue in the United States : Results from the DELIVER High Risk real-world study.
Sullivan SD, Freemantle N, Gupta RA, Wu J, Nicholls CJ, Westerbacka J, Bailey TS. Sullivan SD, et al. Endocrinol Diabetes Metab. 2022 Jan;5(1):e00306. doi: 10.1002/edm2.306. Epub 2021 Nov 22. Endocrinol Diabetes Metab. 2022. PMID: 34807513 Free PMC article.
Prescribing Patterns of Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors in Eligible Patients With Clinical Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia.
Karalis DG, Mallya UG, Ghannam AF, Elassal J, Gupta R, Boklage SH. Karalis DG, et al. Among authors: gupta r. Am J Cardiol. 2018 May 15;121(10):1155-1161. doi: 10.1016/j.amjcard.2018.02.002. Epub 2018 Feb 12. Am J Cardiol. 2018. PMID: 29548678 Free article.
Extracorporeal Shock-Wave Lithotripsy and Endoscopy for the Treatment of Pain in Chronic Pancreatitis : A Sham-Controlled, Randomized Trial.
Talukdar R, Olesen SS, Unnisa M, Bedarkar A, Sarkar S, Tandan M, Jagtap N, Darisetty S, Kiran S, Koppoju V, Lakhtakia S, Ramchandani M, Kalapala R, Gupta R, Singh VK, Rao GV, Reddy DN, Drewes AM. Talukdar R, et al. Among authors: gupta r. Ann Intern Med. 2024 May 28. doi: 10.7326/M24-0210. Online ahead of print. Ann Intern Med. 2024. PMID: 38801774
15,377 results
You have reached the last available page of results. Please see the User Guide for more information.